HealthCap Distributes BONESUPPORT Shares to Investors
Deal News | May 26, 2025 | HealthCap Venture Capital
HealthCap V, a venture capital fund part of the HealthCap group, has announced the distribution of all its shares in BONESUPPORT to its limited partners and general partner as part of a planned liquidation of the fund. Prior to the distribution, HealthCap V held approximately 2.6 million shares, representing about 4% of the shares and votes in BONESUPPORT. The shares will be distributed to various Swedish and non-Swedish institutional investors. Dr. Bjrn Odlander, a board member of BONESUPPORT and Managing Partner at HealthCap, stated that HealthCap was an early investor in BONESUPPORT and has been a significant part of its journey since 2006. Despite the liquidation, Dr. Odlander intends to remain on BONESUPPORT's board of directors. HealthCap is known for investing globally in life sciences, supporting over 130 companies, with a focus on diseases with a high unmet medical need and transformative therapies. BONESUPPORT, headquartered in Lund, Sweden, focuses on innovative bone graft substitutes and has reported net sales of SEK 899 million in 2024.
Sectors
- Venture Capital
- Life Sciences
- Medical Devices
Geography
- Sweden – BONESUPPORT is based in Lund, Sweden, and Swedish institutional investors are recipients of the distributed shares.
- Europe – HealthCap is a European venture capital firm investing on a global scale.
Industry
- Venture Capital – The article involves HealthCap, a venture capital firm that invests in life sciences companies globally.
- Life Sciences – HealthCap invests in life sciences, and BONESUPPORT develops innovative bio-ceramic bone graft substitutes that align with this sector.
- Medical Devices – BONESUPPORT specializes in injectable bio-ceramic bone graft substitutes, a category within medical devices.
Financials
- 2.6 million shares – The number of BONESUPPORT shares held by HealthCap V prior to distribution, representing about 4% of the shares and votes in the company.
- SEK 899 million – Net sales figure for BONESUPPORT in 2024.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| HealthCap | Private Equity/Venture Capital Firm | Company | A European venture capital firm that invests globally in life sciences and has been operational since 1996. |
| HealthCap V LP | Fund | Company | A venture capital fund within the HealthCap group responsible for the investment in BONESUPPORT. |
| BONESUPPORT | Target Company | Company | A company that develops and commercializes bio-ceramic bone graft substitutes. |
| Dr. Bjrn Odlander | Board Member, Managing Partner | Person | Board member of BONESUPPORT and Managing Partner at HealthCap. |